Sukhovershin, Roman A.
Cooke, John P.
Funding for this research was provided by:
National Institutes of Health (U01 HL100397)
Article History
First Online: 27 January 2016
Compliance with Ethical Standards
:
: This study was funded in part by a Grant to Dr. Cooke from the National Institutes of Health (U01 HL100397).
: Stanford University holds patents on therapeutic modulation of the nitric oxide synthase pathway, and on therapeutic uses of proton pump inhibitors, on which Dr. Cooke is an inventor. Dr. Sukhovershin declares that he has no conflict of interest.